| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2019-12-31 | SC | Roivant Sciences Ltd. | — | — | view → |
| 2019-07-17 | SC | Lo Andrew | — | — | view → |
| 2019-07-16 | SC | Machado Patrick | — | — | view → |
| 2019-07-16 | SC | Roivant Sciences Ltd. | — | — | view → |
| 2019-07-12 | SC | VIKING GLOBAL INVESTORS LP | — | — | view → |
| 2019-07-12 | SC | Dexxon Holdings Ltd. | — | — | view → |
| 2019-07-12 | SC | QVT Financial LP | — | — | view → |
| 2019-07-12 | SC | SVF Investments (UK) Ltd | — | — | view → |
| 2019-03-19 | SC | Machado Patrick | — | — | view → |
| 2019-03-19 | SC | Roivant Sciences Ltd. | — | — | view → |
| 2019-03-19 | SC | QVT Financial LP | — | — | view → |
| 2019-03-19 | SC | Dexxon Holdings Ltd. | — | — | view → |
| 2019-03-19 | SC | VIKING GLOBAL INVESTORS LP | — | — | view → |
| 2019-03-19 | SC | Lo Andrew | — | — | view → |
| 2019-03-19 | SC | SVF Investments (UK) Ltd | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-04-02 | SCHEDULE 13D/A | BridgeBio Pharma, Inc. BBIO | 6.10% | 11,842,434 | view → |
| 2025-07-01 | SCHEDULE | BridgeBio Pharma, Inc. BBIO | 9.80% | 18,602,920 | view → |
| 2025-01-31 | SCHEDULE | BridgeBio Pharma, Inc. BBIO | 11.70% | 22,055,375 | view → |
| 2021-10-01 | SC | Ginkgo Bioworks Holdings, Inc. DNABW | — | — | view → |
| 2019-07-12 | SC | Myovant Sciences Ltd. | — | — | view → |
| 2019-07-12 | SC | Axovant Gene Therapies Ltd. | — | — | view → |
| 2019-07-12 | SC | Urovant Sciences Ltd. | — | — | view → |
| 2019-07-12 | SC | Arbutus Biopharma Corp ABUS | — | — | view → |
| 2019-03-19 | SC | Axovant Sciences Ltd. | — | — | view → |
| 2019-01-03 | SC | Arbutus Biopharma Corp ABUS | — | — | view → |
| 2019-01-03 | SC | Urovant Sciences Ltd. | — | — | view → |
| 2018-01-16 | SC | Arbutus Biopharma Corp ABUS | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.
Request a pilot →